Preparation and Evaluation of Cefixime Dispersible Tablets Using Co- Processed Excipients

Select Content Type
Resources
Authored By
Shalina MedSpace
Authored On
Interests
Cardiology
Dermatology
Emergency Medicine
Endocrinology
ENT
Gastroenterology
Hematology
Immunology Allergy & Inflammation
Infectious Disease & Vaccines
Internal/Family Medicine
Neurology
Obstetrics & Gynecology
Oncology
Ophthalmology
Orthopedic
Pain & Anesthesiology
Pediatric Medicine
Psychiatry
Pulmonology
Radiology
Rheumatology
Surgery
Urology & Nephrology
Speciality
Cardiology
Dentistry
Dermatology
Emergency Medicine
Endocrinology
ENT
Gastroenterology
Geriatrics
Hematology
Immunology Allergy & Inflammation
Infectious Disease & Vaccines
Internal/Family Medicine
Medical Genetics
Neurology
Obstetrics & Gynecology
Oncology
Ophthalmology
Orthopedic
Pain & Anesthesiology
Pathology
Pediatric Medicine
Pharmacology
Psychiatry
Public Health
Pulmonology
Radiology
Rheumatology
Surgery
Urology & Nephrology
Thumbnail Image
prep & eval_thumbnail
Detail Image
prep & eval_mobile
Book Detail
Actions
Download in App
Countries of release
India
Nigeria
UAE
IS_Ebsco
false
Description

A study found that cefixime dispersible tablets formulated with crospovidone as a superdisintegrant can deliver faster disintegration and dissolution, offering a more efficient alternative to existing marketed formulations. The choice of superdisintegrant and compression method was found to significantly influence tablet hardness and wetting time. Key findings revealed that the formulation containing 10% crospovidone (CP), exhibited favorable results—achieving a disintegration time of 25 seconds and a wetting time of 20 seconds. In addition, the formulation showed a rapid dissolution rate, reaching 80% drug release within 0.75 minutes.

Published Date